Although BBR sensitizes and induces TRAIL-mediated apoptosis in human renal cancer cells by downregulating c-FLIP and Mcl-1 (25), little is known with regard to the therapeutic potential of BBR and its associated compounds in combination with TRAIL. This evidence concerns the gene TNFSF10 and renal carcinoma.